The Reception | Tuesday 25th May 2021 | 18:00 - 20:00 

The Danish Embassy, The Ambassador's Residence, 2 Hans Street, London, SW1X ONJ


The Conference | Wednesday 26th May 2021 | 08:15 - 18:30

8:15    Registration opens, full continental breakfast is served

9:00    Welcome 

Mattias Johansson, Director, Ezenze Ltd, Anglonordic Conference Founder 

Morning session Chaired by Mary Clark, Managing Director, Optimum Strategic Communications

9:05     Keynote

9:30     What’s hot and what's simmering? - Investment Panel Discussion

10:30   Coffee

11:00   Company Presentations

Biotech Investment Room and Technology Room
Presentations include VAXIMM, a privately held Swiss/German biotech company that is developing oral T-cell immunotherapies
Apply to pitch here.


12:30 - 13:30    Networking Lunch


Afternoon session 

13:30    DDR Therapeutics - Panel discussion

14:30    Company Presentations

Biotech Investment Room and Technology Room
Presentations: to be announced soon! Apply to pitch here.

15:45    Coffee

16:00    Building your Board - Structure, Diversity, Success - Panel Discussion

16:45    If I knew then what I know today - Panel Discussion

17.45    Conclusions

17.55 - 18:45   Drinks Reception

Hosted by Mattias Johansson, Director, Ezenze Ltd


1:1 meetings take place throughout the day and are pre-booked online. 

Login to add your profile, bookmark prospects and book meetings.


Investors registered so far: 
Advent Life Science, Albion Technology & General VCT, Alpha Blue Ocean, Alpha Bronze Life Sciences Opportunities Fund, Apollo Ventures, Aratus Capital, Arvic AG, Axon Capital Partners, Bioscience Managers, Biotechnology Business Institute, Bond Asian Ventures, Cascara Ventures Bvba, Catapult Ventures, DeBere Capital Partners, Eli Lilly, ESM Biotech, Esperante, GL Capital, Helsinn Investment Fund, Hermes Partners Intl, Ignite Capital Partners, Inkef Capital, Innovate UK, IP Group, IPF Partners, Kreos Capital, Kurma Partners, Lundbeckfonden Emerge, Lundbeckfonden Ventures, Luminous Ventures, M Ventures, Mercia Asset Management, NeoMed, Newables, Norgine Ventures, o2h Ventures, Optum Ventures, oxford technology 3, Panakes Partners, Pontifax, Questra, Rosetta Capital, Seroba Life Sciences, Seventure Partners, Swelife International, Syncona, Syndicate Room, Trilantic Europe, UCB Ventures, UK Innovation & Science Seed Fund, Xeraya Capital and XOventure.